Bessemer Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.83M | Hold |
|
|||||
|
2025
Q2 | $3.48M | Hold |
|
|||||
|
2025
Q1 | $3.64M | Hold |
|
|||||
|
2024
Q4 | $5.76M | Sell |
|
|||||
|
2024
Q3 | $6.88M | Buy |
|
|||||
|
2024
Q2 | $6.39M | Sell |
|
|||||
|
2024
Q1 | $5.25M | Hold |
|
|||||
|
2023
Q4 | $3.69M | Hold |
|
|||||
|
2023
Q3 | $2.81M | Hold |
|
|||||
|
2023
Q2 | $3.57M | Hold |
|
|||||
|
2023
Q1 | $3.17M | Hold |
|
|||||
|
2022
Q4 | $3.92M | Hold |
|
|||||
|
2022
Q3 | $4.66M | Buy |
|
|||||
|
2022
Q2 | $3.86M | Hold |
|
|||||
|
2022
Q1 | $4.27M | Buy |
|
|||||
|
2021
Q4 | $8.82M | Sell |
|
|||||
|
2021
Q3 | $9.85M | Buy |
|
|||||
|
2021
Q2 | $8.09M | Hold |
|
|||||
|
2021
Q1 | $9.47M | Buy |
|